1 / 32

The Antihyperlipidemic Medications

The Antihyperlipidemic Medications. Classifications of Lipoproteins Chylomicrons Formed in the mucosal cells of the gut Protein coated dietary lipids. Carried in the blood to fat depots and transported across the vasculature with the help of Capillary-Bound LPL

lali
Download Presentation

The Antihyperlipidemic Medications

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Antihyperlipidemic Medications • Classifications of Lipoproteins • Chylomicrons • Formed in the mucosal cells of the gut • Protein coated dietary lipids

  2. Carried in the blood to fat depots and transported across the vasculature with the help of Capillary-Bound LPL • Chylomicron remnants goes back to the liver to be used to synthesize TGs

  3. Very Low Density Lipoproteins (VLDL) • Triglyceride rich particle • Made in the liver • VLDL is the transport form for TGs made in the liver going to the periphery

  4. Cholesterol containing particle • LPL transports TGs into fat depots • Remainder is a cholesterol rich particle now called LDL

  5. Low Density Lipoprotein (LDL) • Contains the major portion of the plasma cholesterol • Associated with a higher risk for CAD

  6. In the liver LDL is recycled for its cholesterol content • LDL in the liver acts to regulate liver uptake of additional LDL

  7. High Density Lipoprotein (HDL) • These particles scavenge cholesterol from the peripheral vessels • Carries cholesterol back to the liver to be used for steroid synthesis, hormone synthesis or the making of bile salts

  8. Types of hyperlipoproteinemias • Type I - Idiopathic Familial Variety • Decreased VLDL, LDL, & HDL • Elevated TGs, Chylomicrons & cholesterol

  9. Type IIa - Essential Familial Variety • Elevated LDL, TGs & Cholesterol

  10. Type IIb - Familial Combined Variety • Elevated LDL & VLDL

  11. Type IV - Endogenous Hypertriglyceridemia • Elevated VLDL, TGs, & Cholesterol • Early CAD • Positive family history for an MI

  12. The Antihyperlipidemic Drugs • HMG-CoA Reductase Inhibitors • The Fibric Acids • Bile Acid Binding Resins • Nicotinic Acid

  13. HMG-CoA Reductase Inhibitors • Lovastatin (Mevacor) • Simvastatin (Zocor) • Mevastatin (Compactin) • Pravastatin

  14. Mechanism Of Action • HMG-CoA Reductase Inhibitors • Blocks the synthesis of cholesterol in the liver by inhibiting the rate limiting enzyme called HMG-CoA Reductase

  15. There is a compensatory drop in plasma LDL due to the up-regulation of the LDL receptor and enhanced clearance of LDL from the plasma

  16. These medications may lower the cholesterol content of the VLDL particle such that when VLDL disposes of its TGs becoming LDL, there is an enhanced attraction for the cholesterol poor LDL particle and its receptor - greater LDL clearance

  17. Adverse Side Effects • Flatulence & Diarrhea • Dyspepsia (Indigestion) • Headaches • Elevations of the liver enzymes - CPK, LDH, and AST - due to hepatotoxicity

  18. Medical Uses • To treat hypercholesterolemia (>250 mg/dl) • Patients with elevated LDL, VLDL & TGs

  19. The Fibric Acids • Gemfibrozil (Lopid) • Clofibrate (Atromide-S)

  20. Mechanisms of Action • Decrease TG synthesis • Decrease liver lipoprotein synthesis • Decrease the excretion of lipoproteins from the liver, especially VLDL

  21. Decrease the synthesis of cholesterol • Increase the production of sterols • Increases the blood levels of HDL

  22. Medical Uses • Lower cholesterol • Lower serum triglycerides • Lower VLDL levels • Lower LDL levels • These drugs are cardioprotective

  23. Adverse Side Effects • GI distress - diarrhea, nausea, vomiting • Alopecia - loss of hair • lower testosterone levels and impotence

  24. Gall stone formation • Hepatotoxic - liver enzymes - LDH, CPK, & AST

  25. Bile Acid Binding Resins • Cholestyramine (Questran) • Colestipol (Colestid)

  26. Mechanism of Action • Bind bile salts in the gut • Bile Acid Binding Resins are not absorbed across the gut into the blood - bile and cholesterol are irreversibly bound in the gut and disposed of in the feces

  27. The net effect - causes the liver to scavenge more cholesterol from the body to make additional bile salts • Liver up-regulates the LDL receptors clearing more LDL from the blood

  28. Adverse Side Effects • Nausea, Vomiting • Indigestion • Flatulence • Constipation • Binds to other medications

  29. Nicotinic Acid • Mechanism of Action • Inhibits the liver from secreting VLDL • Reduces the blood levels of LDL

  30. Inhibits the destruction of HDL thus allowing a permissive rise in HDL • Niacin increases the excretion of sterols in the feces thus using up more cholesterol

  31. Adverse Side Effects • Flushing • Vomiting • Nausea • Dyspepsia • Flatulence

  32. Medical Uses • To reduce VLDL • To reduce LDL • To increase HDL • Given to most hyperlipidemics

More Related